| 논문분류 | 춘계학술대회 초록집 |
|---|---|
| 제목 | The Cardiac Troponin T for Predicting Coronary Artery Disease in Patients with Chronic Kidney Disease |
| 저자 | Se Won Oh1, Su Ah Sung1, Ji Young Park1, Sung Kee Ryu2, Jae Woong Choi2, So Young Lee1 |
| 출판정보 | 2013; 2013(1): |
| 키워드 | 만성신부전, 관상동맥질환, 트로포닌/Chronic kidney disease, Coronary artery disease, Troponin T |
| 초록 | Backgrounds: Chronic kidney disease (CKD) patients frequently have a notably elevated cardiac troponin (cTnT) level without a coronary event. Therefore, there is concern that the correlation between cTnT and CAD may be poor in CKD patients. The aim of the study was to assess the appropriate cTnT levels for predicting coronary artery disease (CAD) in early and late stages of CKD patients. Methods: We identified 2,732 adults, aged 18 years or older, who had undergone coronary angiography (CAG) between January 2004 and April 2011 at a single center. cTnT and eGFR were measured before the CAG examination. Results: CAD was confirmed in 53.9% patients. cTnT levels were detected in 21.2% of CAD patients and 3.81% of non-CAD patients. In patients with an eGFR<30 ml/min/1.73m2, cTnT levels were significantly elevated regardless of the presence or absence of CAD. However, cTnT levels were significantly correlated with the severity of CAD in patients with an eGFR<30 ml/min/1.73m2 and between 30 and 59 ml/min/1.73m2 (p<0.02). Multivariate analysis revealed that the risk of CAD was correlated with cTnT level, even in patients with reduced renal function. In patients with an eGFR≥60 ml/min/1.73m2, cTnT≥0.01 ng/ml was associated with significant CAD risk, as was cTnT≥0.1 ng/ml in patients with an eGFR 30-59 ml/min/1.73m2, and cTnT≥0.2 ng/ml in patients with an eGFR<30 ml/min/1.73m2. Conclusion: Similar to general population analysis, progressively higher levels of cTnT predicted the increased risk of CAD in CKD patients. And cTnT≥0.2 ng/ml had a significantly increased CAD risk in patients with eGFR<30 ml/min/ 1.73m2. |
| 원문(PDF) | PDF 원문보기 |